Phase 2 Trial Using Talampanel in Patients With Recurrent High Grade Gliomas
- Study Title
- Phase 2 Trial Using Talampanel in Patients With Recurrent High Grade Gliomas
- Teva Identifier
- IXR-205-21-189
- ClinicalTrials.gov Identifier
- NCT00062504
- Study Status
- Terminated
- Trial Condition(s)
- Glioblastoma Multiforme|Anaplastic: Astrocytoma,Oligodendroglioma|Anaplastic Mixed Oligoastrocytoma
- Interventions
- Drug: Talampanel
- Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Adult, Older Adult
- Age Range
- 18 Years and older
- Trial Duration
- 07/01/2003 - 04/01/2006
- Phase
- Phase 2
